• non-small cell lung cancer pipeline 2025: mechanism of action, openPR.com Fri, 25 Apr 2025 21:45:00 GMT
• methylgene inc. announces the appointment of mark j. gergen as executive vice president and coo marketscreener.com Sun, 13 Apr 2025 02:05:07 GMT
• updated krystal-7 data show pfs beyond 27 months for adagrasib plus pembro in first-line treatment of kras-mutated nsclc AJMC Fri, 28 Mar 2025 16:58:39 GMT
• non-small cell lung cancer market set to grow substantially through 2034, delveinsight projects | abbvie, xcovery, sanofi, neoimmu... Barchart.com Wed, 26 Mar 2025 13:04:00 GMT
• non-small cell lung cancer pipeline 2025: key companies, moa, roa, and clinical trials evaluation by delveinsight | abbvie, xcover... Barchart Fri, 21 Mar 2025 13:34:41 GMT
• methylgene inc. announces management changes -march 14, 2013 at 09:32 am edt Marketscreener.com Tue, 11 Mar 2025 00:08:53 GMT
• braf mutated non-small cell lung cancer market predicted to see upsurge through 2032, highlights delveinsight | abbvie, xcovery, s... Barchart Wed, 05 Mar 2025 21:51:12 GMT
• bridgebio oncology to go public in spac deal bringing $450 million-plus for trio of cancer drugs Dealbreaker Mon, 03 Mar 2025 08:00:00 GMT
• bluebird, facing cash crunch, to go private in deal valued at $30m BioSpace Fri, 21 Feb 2025 14:40:09 GMT
• What's Going On With Gene Therapy Company Bluebird Bio Stock Today? Benzinga Fri, 21 Feb 2025 08:00:00 GMT
• carlyle and sk capital to take gene therapy firm bluebird bio private pehub.com Fri, 21 Feb 2025 08:00:00 GMT
• eu regulator declines to support mirati's lung cancer drug BW Healthcare World Sat, 08 Feb 2025 05:03:45 GMT
• combined strategy can prevent pancreatic cancer drug resistance BioWorld MedTech Fri, 31 Jan 2025 08:00:00 GMT
• mirati therapeutics phase 3 non-small cell lung cancer trial fails to meet primary endpoint; shares drop premarket Marketscreener.com Mon, 20 Jan 2025 14:12:17 GMT
• mirati therapeutics reportedly attracts fresh takeover interest Marketscreener.com Mon, 30 Dec 2024 12:27:21 GMT
• Iambic Therapeutics Announces Appointment of Peter Olson, Ph.D., as Chief Scientific Officer BioSpace Wed, 11 Dec 2024 08:00:00 GMT
• iambic therapeutics appoints peter olson, ph.d. as chief scientific officer citybiz Wed, 11 Dec 2024 08:00:00 GMT
• eu regulator declines to support mirati's lung cancer drug BW Businessworld Sun, 08 Dec 2024 23:31:18 GMT
• alx oncology hires genentech, mirati vet as new cmo; after carmot, heather turner has three new roles on tap Endpoints News Fri, 15 Nov 2024 12:00:00 GMT
• ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap Endpoints News Fri, 15 Nov 2024 08:00:00 GMT
• ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer GlobeNewswire Thu, 14 Nov 2024 08:00:00 GMT
• alx oncology appoints former mirati & genentech exec as chief medical officer StockTitan Thu, 14 Nov 2024 08:00:00 GMT
• aurinia pharmaceuticals strengthens board with biotech finance veteran craig johnson StockTitan Thu, 07 Nov 2024 08:00:00 GMT
• Mirati team demonstrates that their KRAS G12C drug is active in NSCLC — but how do they stack up next to Amgen? Endpoints News Tue, 29 Oct 2024 07:00:00 GMT
• mirati therapeutics receives untitled letter from opdp for overstating cancer drug efficacy Policy & Medicine Mon, 28 Oct 2024 07:00:00 GMT
• certain pre-funded warrants of mirati therapeutics, inc. are subject to a lock-up agreement ending on 27-dec-2020. Marketscreener.com Sat, 26 Oct 2024 22:37:01 GMT
• metastatic colorectal cancer pipeline 2024: clinical trials assessment, fda approvals, therapies, and key companies involved by de... Barchart Thu, 24 Oct 2024 07:00:00 GMT
• colorectal cancer pipeline overview 2024: fda approvals and key companies involved by delveinsight | novartis, pharma oncology, pu... The Globe and Mail Mon, 21 Oct 2024 14:39:45 GMT
• jmp securities upgrades mirati therapeutics to market outperform from market perform; price target is $72 Marketscreener.com Sun, 20 Oct 2024 00:23:57 GMT
• pd-1 non-small cell lung cancer market growth to accelerate in forecast period (2024-2034), delveinsight analyzes | abbvie, xcover... The Globe and Mail Wed, 16 Oct 2024 07:00:00 GMT
• mirati therapeutics receives untitled letter from opdp for overstating cancer drug efficacy Policy & Medicine Sat, 12 Oct 2024 08:04:27 GMT
• kras inhibitors market: new treatments are set to change cancer care | delveinsight Yahoo Finance Mon, 30 Sep 2024 07:00:00 GMT
• bristol myers squibb's krazati bests chemo in kras-mutant nsclc with brain metastases Precision Medicine Online Sun, 15 Sep 2024 07:00:00 GMT
• #esmo24 roundup: new data on amgen’s prmt5 inhibitor seem lackluster, and jazz’s her2 antibody Endpoints News Mon, 09 Sep 2024 07:00:00 GMT
• misconstruing single-arm study data lands bms in trouble with us fda Pink Sheet Mon, 26 Aug 2024 06:45:39 GMT
• bristol myers squibb to acquire mirati therapeutics in deal worth up to $5.8 billion MSN Sat, 17 Aug 2024 22:36:10 GMT
• krazati untitled letter: a cautionary tale for cfl promotion of accelerated approval drugs JD Supra Thu, 15 Aug 2024 07:00:00 GMT
• Krazati Untitled Letter: A Cautionary Tale for CFL Promotion of Accelerated Approval Drugs NatLawReview.com Wed, 14 Aug 2024 07:00:00 GMT
• mirati gets opdp untitled letter for misrepresenting cancer drug efficacy Regulatory Focus Fri, 09 Aug 2024 12:33:19 GMT
• misconstruing single-arm study data lands bms in trouble with us fda Pink Sheet Thu, 08 Aug 2024 20:56:57 GMT
• FDA blasts Bristol Myers over misleading Krazati efficacy claims Fierce Pharma Thu, 08 Aug 2024 07:00:00 GMT
• Mirati gets OPDP untitled letter for misrepresenting cancer drug efficacy Regulatory Affairs Professionals Society | RAPS Thu, 08 Aug 2024 07:00:00 GMT
• avidity biosciences announces appointment of john b. moriarty, jr. as chief legal officer PR Newswire Mon, 05 Aug 2024 13:00:00 GMT
• Mirati's Charles Baum takes the helm at Terremoto Biosciences Fierce Biotech Thu, 25 Jul 2024 07:00:00 GMT
• Exclusive: After selling Mirati to BMS for nearly $5B, Chuck Baum lands at another ‘undruggable’ company Endpoints News Thu, 25 Jul 2024 07:00:00 GMT
• terremoto biosciences appoints charles baum, m.d., ph.d., as chief executive officer Business Wire Thu, 25 Jul 2024 07:00:00 GMT
• mirati therapeutics announces pricing of upsized public offering Quantisnow Thu, 11 Jul 2024 15:09:43 GMT
• bristol myers sees $0.35 per share charge as mirati acquisition completes MSN Thu, 04 Jul 2024 15:08:53 GMT
• [key companies] small molecule drug cdmo services market gliead, boehringer ingelheim, vertex, mirati ... Economica Thu, 04 Jul 2024 05:11:58 GMT
• update 4-bristol-myers squibb to acquire mirati in up to $5.8 billion deal Yahoo Sport Australia Fri, 28 Jun 2024 14:47:32 GMT
• tiger biotherapeutics describes new kras mutant degraders BioWorld Online Fri, 28 Jun 2024 07:00:00 GMT
• mirati's (mrtx) krazati gets breakthrough therapy tag for crc Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
• mirati therapeutics reports second quarter 2022 financial results and recent corporate updates Quantisnow Thu, 27 Jun 2024 14:11:38 GMT
• asymchem appoints dr. cheng yi chen as cto of small-molecule sector Business Wire Wed, 26 Jun 2024 07:00:00 GMT
• mirati's (mrtx) stock rallies 11% on buyout speculations Yahoo News Australia Tue, 25 Jun 2024 20:33:52 GMT
• fda approves bristol myers squibb's combination therapy for colorectal cancer patients with certain type of gene ... AOL Mon, 24 Jun 2024 14:25:58 GMT
• fda grants accelerated approval to krazati with erbitux for kras g12c–mutated colorectal cancer Clinical Oncology News Mon, 24 Jun 2024 14:23:58 GMT
• FDA Grants Accelerated Approval to Krazati for Colorectal Cancer Managed Healthcare Executive Mon, 24 Jun 2024 07:00:00 GMT
• BMS, Mirati's Krazati cements lead over Amgen's Lumakras with FDA approval in colorectal cancer Fierce Pharma Mon, 24 Jun 2024 07:00:00 GMT
• bms expands krazati’s fda label to include colorectal cancer Pharmaceutical Technology Mon, 24 Jun 2024 07:00:00 GMT
• bms expands krazati's fda label to include colorectal cancer Pharmaceutical Technology Mon, 24 Jun 2024 07:00:00 GMT
• mirati (mrtx) expected to beat earnings estimates: what to know ahead of q3 release Yahoo Singapore News Fri, 21 Jun 2024 23:42:02 GMT
• mirati (mrtx) reports q2 loss, tops revenue estimates Yahoo Lifestyle UK Sat, 15 Jun 2024 14:38:07 GMT
• mirati's (mrtx) stock rallies 11% on buyout speculations Yahoo News Australia Fri, 14 Jun 2024 02:50:00 GMT
• analyst forecasts just became more bearish on mirati therapeutics, inc. (nasdaq:mrtx) Yahoo New Zealand News Fri, 14 Jun 2024 02:23:00 GMT
• bms chief christopher boerner says company is still open to deals after spending more than $20b on m&a last year Fierce Pharma Wed, 12 Jun 2024 07:00:00 GMT
• non-small cell lung cancer market to register incremental growth during the forecast period (2023-2032), asserts ... Barchart Mon, 10 Jun 2024 12:54:00 GMT
• need to know: the consensus just cut its mirati therapeutics, inc. (nasdaq:mrtx) estimates for 2020 Yahoo Movies UK Wed, 05 Jun 2024 14:53:24 GMT
• asco 2024: bristol myers confirms krazati benefit with krystal-12 results The Pharma Letter Mon, 03 Jun 2024 07:00:00 GMT
• asco 2024: adagrasib shows statistically significant improvement in pfs in krasg12c-mutated nsclc OncoZine Sun, 02 Jun 2024 06:04:03 GMT
• asco 2024: adagrasib shows statistically significant improvement in pfs in krasg12c-mutated nsclc OncoZine Sat, 01 Jun 2024 07:00:00 GMT
• mirati to focus adagrasib/keytruda study in low pdl1 lung cancer patients Yahoo Movies Canada Tue, 28 May 2024 11:53:06 GMT
• why mirati therapeutics (mrtx) might surprise this earnings season Yahoo News UK Sat, 25 May 2024 18:00:25 GMT
• mirati therapeutics (nasdaq:mrtx) shareholders have endured a 57% loss from investing in the stock three years ago Yahoo Canada Shine On Sat, 25 May 2024 12:43:33 GMT
• bristol myers updates action date for subcutaneous opdivo Markets Insider Thu, 23 May 2024 07:00:00 GMT
• update 2-sanofi to explore acquisition of cancer drugmaker mirati- bloomberg news Yahoo Canada Shine On Wed, 22 May 2024 23:09:48 GMT
• the undruggable cancer target: kras inhibitors move ahead in the clinic Labiotech.eu Wed, 22 May 2024 07:00:00 GMT
• neurofibrosarcoma market is expected to expand at a healthy growth rate during the forecast period | ascentage ... Barchart Mon, 20 May 2024 22:28:00 GMT
• why mirati therapeutics (mrtx) might surprise this earnings season Yahoo News UK Mon, 20 May 2024 06:11:00 GMT
• why mirati therapeutics (mrtx) might surprise this earnings season Yahoo News UK Sat, 18 May 2024 13:18:07 GMT
• update 2-sanofi to explore acquisition of cancer drugmaker mirati- bloomberg news Yahoo Canada Shine On Sat, 18 May 2024 11:42:30 GMT
• bristol myers squibb to buy mirati therapeutics in deal worth up to $5.8 billion MSN Sat, 18 May 2024 07:24:51 GMT
• bristol myers strikes deal to buy mirati therapeutics for up to $5.8 billion MSN Sat, 18 May 2024 05:13:24 GMT
• mirati (mrtx) beats on q3 earnings, begins nda adagrasib filing Yahoo New Zealand News Wed, 15 May 2024 13:31:25 GMT
• mirati therapeutics (nasdaq:mrtx) shareholders have endured a 57% loss from investing in the stock three years ago Yahoo Canada Shine On Wed, 15 May 2024 04:04:44 GMT
• growth investors: industry analysts just upgraded their mirati therapeutics, inc. (nasdaq:mrtx) revenue forecasts ... Yahoo Canada Shine On Tue, 14 May 2024 16:04:32 GMT
• mirati (mrtx) reports q2 loss, tops revenue estimates Yahoo New Zealand News Tue, 14 May 2024 15:18:50 GMT
• even after rising 4.0% this past week, mirati therapeutics (nasdaq:mrtx) shareholders are still down 76% over the ... Yahoo Canada Shine On Mon, 13 May 2024 19:56:53 GMT
• what you need to know about the mirati therapeutics, inc. (nasdaq:mrtx) analyst downgrade today Yahoo Movies UK Mon, 13 May 2024 03:47:02 GMT
• one to watch companies - nephrology and hepatology, mirati therapeutics The Pharma Letter Thu, 09 May 2024 19:25:07 GMT
• one to watch companies - us fda, mirati therapeutics, priority review The Pharma Letter Thu, 09 May 2024 00:29:41 GMT
• one to watch companies - us fda, mirati therapeutics, priority review The Pharma Letter Wed, 08 May 2024 23:32:55 GMT
• tolremo welcomes dr. alan sandler to scientific advisory board Business Wire Wed, 08 May 2024 09:00:00 GMT
• merck and other pharma giants are bracing for competition to their blockbuster drugs. here's how Quartz Wed, 08 May 2024 07:00:00 GMT
• one to watch companies - us fda, mirati therapeutics, priority review The Pharma Letter Tue, 07 May 2024 19:52:06 GMT
• is a surprise coming for mirati (mrtx) this earnings season? Yahoo Singapore News Tue, 07 May 2024 05:35:00 GMT
• mirati (mrtx) down 23% on mixed data from lung cancer study Yahoo Singapore News Mon, 06 May 2024 14:39:11 GMT
• one to watch companies - us fda, mirati therapeutics, priority review The Pharma Letter Mon, 06 May 2024 07:16:21 GMT
• rocket pharmaceuticals reports first quarter 2024 financial results and highlights recent progress Business Wire Mon, 06 May 2024 07:00:00 GMT
• update 1-mirati to focus adagrasib/keytruda study in low pdl1 lung cancer patients Yahoo Lifestyle Australia Mon, 06 May 2024 04:08:42 GMT
• bristol-myers squibb to acquire mirati in up to $5.8 billion deal Yahoo Lifestyle UK Sun, 05 May 2024 16:31:57 GMT
• mirati's lung cancer drug fails to win eu regulator's backing Yahoo Canada Shine On Fri, 03 May 2024 03:28:34 GMT
• mirati's lung cancer drug fails to win eu regulator's backing Yahoo Canada Shine On Thu, 02 May 2024 13:51:39 GMT
• bridgebio spinout launches with $200m for kras cancer drugs Yahoo Finance Thu, 02 May 2024 07:00:00 GMT
• one to watch companies - us fda, mirati therapeutics, arcalyst The Pharma Letter Tue, 30 Apr 2024 16:45:30 GMT
• $2.4b ono purchase of deciphera highlights recent m&a activity BioSpace Tue, 30 Apr 2024 06:54:03 GMT
• $2.4b ono purchase of deciphera highlights recent m&a activity BioSpace Mon, 29 Apr 2024 23:09:45 GMT
• bristol-myers squibb shells out billions for mirati: 5 big deal reports Yahoo Movies UK Sun, 28 Apr 2024 21:52:37 GMT
• bms decision to lay off 2,200 employees comes after m&a spending spree BioSpace Fri, 26 Apr 2024 07:00:00 GMT
• bristol myers squibb reports first quarter financial results for 2024 Business Wire Thu, 25 Apr 2024 07:00:00 GMT
• bristol myers squibb signs $380 million deal with cellares European Pharmaceutical Manufacturer Tue, 23 Apr 2024 07:00:00 GMT
• genfleet’s kras g12c inhibitor moving into phase iii BioWorld Online Tue, 23 Apr 2024 07:00:00 GMT
• mirati (mrtx) reports q3 loss, tops revenue estimates Yahoo Movies UK Mon, 22 Apr 2024 16:08:54 GMT
• mirati's (mrtx) adagrasib gets breakthrough therapy status Yahoo Movies UK Sat, 20 Apr 2024 22:26:43 GMT
• biopharma layoff tracker 2024: sanofi, vedanta, fujifilm and more cut staff BioSpace Sat, 20 Apr 2024 08:36:42 GMT
• biopharma layoff tracker 2024: sanofi, vedanta, fujifilm and more cut staff BioSpace Fri, 19 Apr 2024 07:00:00 GMT
Mirati Therapeutics, Inc(NASDAQ:MRTX) 
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NS...
Website: http://www.mirati.com
Founded: 1995
Full Time Employees: 111
Sector: Healthcare
Industry: Biotechnology